Project Details
Description
Randomzd,parallel group,open-label,active controlled,multictr Ph III trial of Patupilone(EPO906)vs pegylated liposomal(Doxil#/Caelyx#)in ...
Status | Finished |
---|---|
Effective start/end date | 12/22/05 → 12/31/13 |
Funding
- NOVARTIS PHARMACEUTICALS CORPORATION